Registrati per grafici in tempo reale, strumenti di analisi e prezzi.

Registrati

Quotazioni in diretta

MD Pediatrix Medical Group Inc

14,59

0,15 (1,04%)

05 Mar 2025 - Chiuso

Dati in Delay di 15 minuti

Form 144 - Report of proposed sale of securities

="/Images/box-checked.jpg" alt="Checkbox checked">

144: Remarks and Signature

Remarks

Date of Notice

11/13/2024

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

Alex Johnson, a duly authorized representative of Piper Sandler & Co Corporate & Venture Services FA, as attorney-in-fact for Mark Ordan

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

Grafico Azioni Pediatrix Medical (NYSE:MD)
Storico
Da Feb 2025 a Mar 2025

Clicca qui per i Grafici di Pediatrix Medical

Grafico Azioni Pediatrix Medical (NYSE:MD)
Storico
Da Mar 2024 a Mar 2025

Clicca qui per i Grafici di Pediatrix Medical

Notizie Pediatrix Medical Group Inc - MD

Form 4 - Statement of changes in beneficial ownership of securities
Martedì 4 Marzo 2025 (1 giorno fa) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Mercoledì 26 Febbraio 2025 (1 settimana fa) • Edgar (US Regulatory)

Form 144 - Report of proposed sale of securities
Venerdì 21 Febbraio 2025 (2 settimane fa) • Edgar (US Regulatory)

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Giovedì 20 Febbraio 2025 (2 settimane fa) • Edgar (US Regulatory)

Form 8-K - Current report
Giovedì 20 Febbraio 2025 (2 settimane fa) • Edgar (US Regulatory)

Pediatrix Medical Group Reports Fourth Quarter Results
Giovedì 20 Febbraio 2025 (2 settimane fa) • Business Wire

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
Giovedì 13 Febbraio 2025 (3 settimane fa) • Edgar (US Regulatory)

Pediatrix Medical Group to Host Premier Neonatology Conference Feb. 19-21
Martedì 11 Febbraio 2025 (3 settimane fa) • Business Wire

Pediatrix Medical Group 2024 Fourth Quarter Conference Call/Webcast Scheduled for Thursday, February 20, 2025
Lunedì 10 Febbraio 2025 (3 settimane fa) • Business Wire

Form 4 - Statement of changes in beneficial ownership of securities
Martedì 14 Gennaio 2025 (2 mesi fa) • Edgar (US Regulatory)

Form 8-K - Current report
Martedì 14 Gennaio 2025 (2 mesi fa) • Edgar (US Regulatory)

Form 8-K - Current report
Lunedì 13 Gennaio 2025 (2 mesi fa) • Edgar (US Regulatory)

Più Pediatrix Medical Group Inc Articoli Notizie

Vontobel Financial Produ...

Vontobel Financial Produ...

Wisdomtree California Ca...

Panorama Real Estate Cre...

KS Aktiengesellschaft

First Nordic Metals

Fundo de Investimento Im...

Vontobel Financial Produ...

Huntington Bancshs

Delayed Upgrade Clock

Per accedere al tempo reale push di Borsa è necessario registrarsi.

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network

ADVFN UK Investors Hub ADVFN Italy ADVFN Australia ADVFN Brazil

ADVFN Canada ADVFN Germany ADVFN Japan ADVFN Mexico

ADVFN France ADVFN US ADVFN Korea